Generic Name and Formulations:
Oxybutynin chloride 10% (1g/sachet); topical gel; contains alcohol.
Indications for GELNIQUE:
Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency.
Apply 1g gel (one sachet) once daily to dry, intact skin on abdomen, upper arm/shoulders, or thighs. Rotate application sites; avoid use of same site on consecutive days. Wash hands after application. Avoid washing area/showering for 1hr after application.
Urinary or gastric retention. Uncontrolled narrow angle glaucoma.
Bladder outflow obstruction. Gastrointestinal obstruction. Decreased GI motility. Ulcerative colitis. Intestinal antony. Gastroesophageal reflux. Esophagitis. Hepatic or renal dysfunction. Myasthenia gravis. Controlled narrow angle glaucoma. Discontinue if skin hypersensitivity or angioedema develops; consider discontinuing if anticholineric CNS effects occur. Skin transference: cover application site with clothing after gel has dried if direct contact is anticipated. Exposure to high environmental temperatures. Gel is flammable. Pregnancy (Cat.B). Nursing mothers.
Caution with drugs that can cause or exacerbate esophagitis (eg, bisphosphonates). Additive effects with other anticholinergics.
Dry mouth, application site reactions (eg, pruritus, dermatitis), urinary tract infection, dizziness, nasopharyngitis, fatigue, headache, constipation, other anticholinergic effects (eg, CNS).
Gel (1g/sachet)—30; Gel 3% pump—92g
- 30 packets of 10% cartons (Qty:1)
- appx. price $237.00
- Public Health Emergency Declared in IN Following HIV Outbreak
- Study: Hospital Readmissions, Length of Stay Greater for C. diff Patients
- Does the Aviation Industry Need Better Mental Health Screening?
- National Strategy to Fight Superbugs Released by the White House
- Gene Mutation May Explain Severe Flu in Healthy Children